QQ客服 官方微博 反馈留言

	Safety and Efficacy of Conbercept in Neovascular Age-Related Macular Degeneration Results from a 12-Month Randomized Phase 2 Study: AURORA Study
	Li, Xiaoxin; Xu, Gezhi; Wang, Yusheng; Xu, Xun; Liu, Xiaoling; Tang, Shibo; Zhang, Feng; Zhang, Junjun; Tang, Luosheng; Wu, Quan
刊名	OPHTHALMOLOGY
	2014
卷号	121期号:9
ISSN号	0161-6420
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4882953
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Li, Xiaoxin,Xu, Gezhi,Wang, Yusheng,et al. Safety and Efficacy of Conbercept in Neovascular Age-Related Macular Degeneration Results from a 12-Month Randomized Phase 2 Study: AURORA Study[J]. OPHTHALMOLOGY,2014,121(9).
APA	Li, Xiaoxin.,Xu, Gezhi.,Wang, Yusheng.,Xu, Xun.,Liu, Xiaoling.,...&Ke, Xiao.(2014).Safety and Efficacy of Conbercept in Neovascular Age-Related Macular Degeneration Results from a 12-Month Randomized Phase 2 Study: AURORA Study.OPHTHALMOLOGY,121(9).
MLA	Li, Xiaoxin,et al."Safety and Efficacy of Conbercept in Neovascular Age-Related Macular Degeneration Results from a 12-Month Randomized Phase 2 Study: AURORA Study".OPHTHALMOLOGY 121.9(2014).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。